GREENWICH, Conn.--(BUSINESS WIRE)--April 10, 2006--Aptuit, Inc. announced today that it has secured additional funding to aid the company in its ongoing efforts to build an industry-leading drug development services organization. Temasek Holdings Limited joined Welsh, Carson, Anderson & Stowe (WCAS), Aptuit's lead investor, with a minority investment, bringing the potential capital available to more than $750 million. Aptuit also announced today the addition of John E. Nine, former Schering-Plough executive and current corporate advisor to Temasek, to its board of directors.
